US Patent 11648213 Transdermal therapeutic system containing asenapine
Patent 11648213 was granted and assigned to LTS Lohmann Therapie-Systeme AG on May, 2023 by the United States Patent and Trademark Office.
All edits
Edits on 14 Aug, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Olga Bourquain0
Patrick Mohr0
René Eifler0
René Rietscher0
Edits on 17 May, 2023
Golden AI
Edits made to:
Infobox (+25 properties)
Article (+510 characters)
US Patent 11648213 Transdermal therapeutic system containing asenapine
Article
The present invention relates to transdermal therapeutic systems (TTS) for the transdermal administration of asenapine comprising a self-adhesive layer structure containing a therapeutically effective amount of asenapine, such asenapine TTS for use in a method of treatment, processes of manufacture of such TTS as well as asenapine and transdermal therapeutic systems containing asenapine for use in a method of treatment and to a method of treating a human patient by transdermal administration of asenapine.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
116482130
Date of Patent
May 16, 2023
0Patent Application Number
172501630
Date Filed
June 19, 2019
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11648213 Transdermal therapeutic system containing asenapine
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.